神经肌肉疾病中的晚期心力衰竭治疗

Advanced Heart Failure Therapies in Neuromuscular Diseases.

作者信息

Agdamag Arianne Clare, Nandar Phoo Pwint, Tang W H Wilson

机构信息

Section of Advanced Heart Failure and Transplantation Medicine, Department of Cardiovascular Medicine, Miller Family Heart, Vascular and Thoracic Institute, Robert and Suzanne Tomsich, Cleveland Clinic, Cleveland, OH 44195, USA.

Section of Advanced Heart Failure, Department of Medicine, MetroHealth Medical Center, Cleveland, OH 44109, USA.

出版信息

Curr Treat Options Cardiovasc Med. 2024 Aug;26(8):255-270. doi: 10.1007/s11936-024-01046-2. Epub 2024 Jun 25.

DOI:10.1007/s11936-024-01046-2

PMID:39777119

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11706575/

Abstract

PURPOSE OF REVIEW

The main objective of this review article is to discuss the prevalence, utilization, and outcomes associated with advanced heart failure therapies among patients with neuromuscular disorders.

RECENT FINDINGS

Neuromuscular disorders often have multisystem involvement with a high prevalence of cardiovascular pathology. With the improvement in management of respiratory related complications, heart failure is now the leading cause of mortality in this patient population. Advanced heart failure therapies with durable left ventricular assist devices and heart transplantation have proven to be feasible and safe treatment options in selected patients.

SUMMARY

Management of neuromuscular disease involves multidisciplinary team involvement given the systemic nature of the disease. Early recognition and close monitoring of these patients will allow for timely initiation of advanced heart failure therapies that can lead to successful outcomes.

摘要